Skip to main content

Table 2 Preoperative NLR and clinical parameters

From: Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study

Variables

Number

NLR (mean ± SD)

p

Gender

 Male

39

2.165 ± 0.980

0.908

 Female

56

2.134 ± 1.474

 

Age

 ≤60

60

2.102 ± 1.335

0.659

 >60

35

2.224 ± 1.218

 

TNM staging of ENETS in 2006

 T1, T2

62

1.909 ± 0.843

0.044

 T3, T4

33

2.594 ± 1.790

 

 N0

80

1.912 ± 0.836

<0.001

 N1

15

3.399 ± 2.282

 

 M0

80

2.094 ± 1.290

0.361

 M1

15

2.427 ± 1.287

 

New grading classifications of WHO in 2010

 NET G1

52

1.862 ± 0.746

0.015

 NET G2

32

2.305 ± 1.597

 

 NEC G3

11

3.031 ± 1.868

 

Tumor thrombus

 Yes

6

3.703 ± 1.573

0.002

 No

89

2.042 ± 1.207

 

Functioning tumor

 Yes

21

2.049 ± 0.874

0.697

 No

74

2.174 ± 1.387

 

AFP

 Normal

91

2.171 ± 1.308

0.384

 Abnormal

4

1.594 ± 0.521

 

CA199

 Normal

93

2.163 ± 1.300

0.396

 Abnormal

2

1.378 ± 0.251

 

CEA

 Normal

91

2.159 ± 1.312

0.665

 Abnormal

4

1.872 ± 0.444

 

CA125

 Normal

92

2.147 ± 1.300

0.979

 Abnormal

3

2.128 ± 1.067

 
  1. NET neuroendocrine tumor, NEC neuroendocrine carcinoma, AFP alpha-fetoprotein, CA199 carbohydrate antigen 199, CEA carcinoembryonic antigen, CA125 carbohydrate antigen 125
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us